• Medical Device Accelerator

    The Medical Device Accelerator at Wake Forest Innovations brings value to industry partners by adding tangible value to licensing deals. Learn how.

  • Characteristics of Successful Technologies

    What are the top characteristics of successful technology opportunities? Dr. Jason Kralic has the answers.

  • APOL1

    Learn how one doctor’s quest to redefine kidney disease in African-Americans is revolutionizing kidney transplantation. Read more.

  • Innovative Science

    Our scientists are developing tomorrow’s innovations in therapeutics, vaccines, medical devices and more. View our technologies available for license.

Discover Innovation

Wake Forest Innovations brings industry and Wake Forest scientists and clinicians together to appreciate each other’s needs and capabilities, determine common goals, devise practical strategies and coordinate efforts to accelerate the process of developing high-value health care products. Discover the innovative work being conducted at Wake Forest.

Partner with Wake Forest

Technology for License

Intellectual Property for License

The Center for Technology Innovation & Commercialization accelerates the development and commercialization of inventions.

View More

Industry Research Collaboration

Industry Research Collaboration

The Center for Industry Research Collaboration expedites access to specialized clinical and research capabilities.

View More

Applied Learning

Center for Applied Learning

The Center for Applied Learning promotes best clinical practices through experiential training.

View More

News and Highlights

Bringing Value to Medical Device Development

When Wake Forest Baptist Medical Center neurosurgeon Charles Branch Jr., MD, found a better way to break up blood clots during traumatic brain injury surgery, he turned to Wake Forest Innovations for help. Over the past year, the Medical Device Accelerator program has transformed his invention into a working prototype of stainless steel, springs and continue reading


Chondrial Therapeutics Secures Financing to Advance Wake Forest Innovations Technology

Chondrial Therapeutics, an emerging biotechnology company focused on the treatment of rare mitochondrial diseases, announced this week that it has secured up to $22.6 million in Series A financing led by Deerfield Management, a health care investment firm located in New York, New York. The financing includes an investment from the Catalyst Fund, a $15 continue reading

Featured Technology

Single-Prong Nasal Cannula

Our single-prong, dual-port nasal cannula simultaneously delivers oxygen deep within the nasal cavity and monitors a patient’s breathing, without blocking the surgical field. In addition, the superior design results in improved procedural safety and reduced anesthetic complications.

 

Learn more.

Facts

Leading and Innovative Technology